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Abstract
Ocular coloboma (OC) is a defect in optic fissure closure and is a common cause of severe congen-
ital visual impairment. Bilateral OC is primarily genetically determined and shows marked locus
heterogeneity. Whole-exome sequencing (WES) was used to analyze 12 trios (child affected with
OC and both unaffected parents). This identified de novo mutations in 10 different genes in eight
probands. Three of these genes encoded proteins associated with actin cytoskeleton dynamics:
ACTG1, TWF1, and LCP1. Proband-onlyWES identified a second unrelated individual with isolated
OC carrying the same ACTG1 allele, encoding p.(Pro70Leu). Both individuals have normal neu-
rodevelopment with no extra-ocular signs of Baraitser–Winter syndrome. We found this mutant
protein to be incapable of incorporation into F-actin. The LCP1 and TWF1 variants each resulted
in only minor disturbance of actin interactions, and no further plausibly causative variants were
identified in these genes on resequencing 380 unrelated individuals with OC.
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Ocular coloboma (OC) is a closure defect affecting epithelial tissues
in the embryonic optic fissure. OC accounts for ∼11% of childhood
blindness and has a birth prevalence of 0.0002–0.0005 (Morrison
et al., 2002; Shah et al., 2012) and most commonly presents as the
absence of iris and/or retina in the inferonasal quadrant of the eye
(Nakamura, Diehl, & Mohney, 2011). OC often co-occurs with ipsi-
and/or contra-lateral microphthalmia (small eye) or contralateral
anophthalmia (absent eye), suggesting that these structural eye
defects can represent a phenotypic continuum (Morrison et al.,
2002). Many of the known OC loci encode transcription factors or
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in anymedium, provided
the original work is properly cited.
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signaling molecules that drive the growth of the optic cup (Chow
& Lang, 2001; Zagozewski, Zhang, & Eisenstat, 2014), suggesting
growth failure as a mechanism for OC occurrence, where fusion-
competent fissure margin cannot appose. Failure of epithelial fusion
is another obvious mechanism, although our knowledge of the genes
and pathways required for this process is limited (Brown et al.,
2009). OC is proving to be genetically heterogeneous (Williamson
& FitzPatrick, 2014) with no individual locus accounting for more
than 3% of cases, and the majority of nonsyndromal OC-affected
individuals (>70%) have no identified genetic cause. Whole-exome
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F IGURE 1 Whole-exomedenovovariant identification. Identificationof 10novel denovovariants in patientswith isolated coloboma from family
trios. Pedigree structures are shown with the gene variant detailed below each pedigree (chromatograms for each individual for whom DNA was
available for targeted Sanger resequencing are presented in Supp. Fig. S1). Probands are indicated with an arrow.
sequencing (WES) within the rare diseases component of the UK10K
project (http://www.uk10k.org/) has been successful in identifying
causative loci in families with OC in YAP1 (http://www.omim.org/,
MIM# 606608) (Williamson et al., 2014), MAB21L2 (MIM#
604537) (Rainger et al., 2014), and FZD5 (MIM# 601723) (Liu et al.,
2016).
Here,we reportWESon12 trios, each comprising one affected indi-
vidual with isolated OC and both unaffected parents. In three of these
trios, there was a wider family history of eye malformation that would
be compatible with nonpenetrance in the intervening parent. DeN-
ovoGear analysis (Ramu et al., 2013), together with a maximumminor
allele frequency in ExAC of <10−4, was used to identify candidate de
novo mutations (DNM) among all technically robust variant calls in
the affected child. Following review and Sanger sequence validation,
10 heterozygous de novo, ultrarare, plausibly disruptive variants were
confirmed in 10 different genes from eight of the trios surveyed (Fig. 1,
and summarized in Supp. Table S1 and Supp. Fig. S1 and have been
deposited in the DECIPHER database [http://decipher.sanger.ac.uk]).
Each trio was also screened for plausibly pathogenic homozygous
or compound heterozygous variants in known developmental disor-
der genes. In proband COL5103597, a causative homozygous loss-
of-function mutation was identified in ADAMTS18, which has been
reported separately (Chandra et al., 2014), and no DNM were iden-
tified in this trio. No other plausible autosomal-recessive genotypes
were identified in the other trios.
The DNM identified in ACTG1 (NM_001199954.1; MIM# 102560)
in COL5231458 (family 12; c.209C>T (p.(Pro70Leu), RNA not ana-
lyzed)) represented a strong candidate becauseDNM in the ubiquitous
cytoplasmic actins (encoded by ACTB and ACTG1) cause Baraitser–
Winter syndrome (BWS) with OC as a prominent feature (MIM#
243310 and 614583) (Di Donato et al., 2014; Rivière et al., 2012).
Review of the WES data from the remaining UK10K OC probands
identified another individual, COL5103624 (family 1,135) with the
identical DNM (c.209 C>T (p.(Pro70Leu), RNA not analyzed)). Clinical
review confirmed that both probands had bilateral irido-chorioretinal
OC, with no involvement of the optic nerve and no evidence of the
neurological and neurodevelopmental impairments that typify BWS.
Neither had hearing loss. Individual COL5103624 had mild bilateral
ptosis. In family 1,135, the mother did not carry the mutation, and the
father was unavailable for testing.
ATP binding to actin, and subsequent hydrolysis to ADP, is coupled
to conformational changes in actinmonomers that appear to be essen-
tial for filament dynamics (Otterbein, Graceffa, & Dominguez, 2001)
and thus actin turnover during dynamic cytoskeletal remodeling. Actin
monomers have four subdomains, structurally organized so that each
presents a surface interface, and arranged such that they converge
around the centrally bound nucleotide. The Pro70 residue in ACTG1
is positioned N-terminal to the previously reported BWS mutations
(Fig. 2A), and is immediately adjacent to thenucleotide-binding domain
of the actinmonomer, in a loop (Pro70-Thr77) that connects theCOOH-
terminal end of subdomain 2 to subdomain 1. This loop undergoes con-
formational reorganization upon ATP hydrolysis, where a 10o rotation
of subdomain 2 occurs, which in turn induces changes to interdomain
interactions that affect the orientation of subdomain 4. In combina-
tion, these are predicted to have major effects on the overall struc-
ture and stability of each actin-ADP polymer (Otterbein et al., 2001).
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F IGURE 2 Functional effects of de novo variants on theACTG1 interactome.A: A scaled cartoon illustrating the positions of the de novo variants
in eachprotein.Domains for eachprotein are indicated: EF-Hand;CH, calponin homology; ADF-H, actin depolymerizing family homology. The LCP1
p.(Asn608Ser) variant is positioned in the fourthCHdomain and the TWF1p.(Pro349Ser) variant is in theC-terminal tail domain of Twinfilin-1. The
p.(Pro70Leu) variant is indicated on the ACTG1model (above), togetherwith knownBaraitser–Winter syndromemutations (below; p.(Ser155Phe)
is a recurrent variant). Inset: a schematic of the actin interactions for Twinfilin-1 and LCP1.B: The intraprotein residue interactions of Pro70 inwild-
type (WT) ACTG1 are depicted on the crystal structure of actin bound to ADP (PDB ID: 1J6Z) on the left panel. The right panel depicts the FoldX
lowest energy conformer formutant Leu70 that indicates significant interatomic clasheswith neighboring side chainsMet82 and Ile85. In silico pro-
tein design algorithm FoldX predicted that the p.(Pro70Leu) change severely destabilizes protein structure with aΔΔG>6.3 kcal/mol, where>1.6
kcal/mol indicates a severely destabilizingmutation.C: Immunofluorescence analyses onMEF cultures obtained fromCRISPR/Cas9-editedmouse
embryos using antibodies specific to Actb andActg1 indicated a reduction of F-actin incorporation for Acgt1 Leu70 comparedwithWT. In contrast,
incorporation of Actb into filaments appeared equivalent in both genotypes. D: Tetracyclin (TET)-inducible HEK293 cell lines expressing either
mutant Leu70 orWT forms ACTG1 tagged with eGFP at the N-terminus were used for standard cosedimentation assays to separate the G- and F-
actin components (G and F, respectively). A significant reduction of themutant proteinwas observed in theG-actin phase (asterisk); however, levels
were comparable toWT in the F-actin phase (top). F- and G-actin were unchanged for endogenous Actg1 (middle) and Actb (below). E: Coimmuno-
precipitation assays using GFP actin as bait were subjected to mass spectrometry and showed that the p.(Pro70Leu) change affected interactions
of Actg1 with multiple known actin-interacting factors (Supp. Table S2). Western blotting confirmed these for twinfilin-1, CAPz� , cofilin, and pro-
filin. In contrast, Leu70 enhanced interactions of Actg1 with multiple subunit components of the chaperonin containing TCP1 complex, confirmed
bywestern blot with an anti-CCT-4 antibody.
A severe destabilizing effect of the mutant Leu70 amino acid change
to the protein was predicted using FoldX (Schymkowitz et al., 2005),
with a difference in free energy of folding (ΔΔG) between mutant and
wild type (WT), of 6.31 kcal/mol in the ADP-bound actin crystal struc-
ture, and ΔΔG 7.4 kcal/mol in the ATP-bound actin crystal structure
(Fig. 2B). Mouse embryonic fibroblasts (MEFs) were derived from
F0 embryos following CRISPR/Cas9 gene editing to create homozy-
gous p.Pro70Leu lines (Supp. Fig. S2). Immunofluorescence showed a
marked reduction of mutant ACTG1 in filamentous F-actin (Fig. 2C)
compared with MEFs from WT littermate control embryos. We then
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created tetracyclin (TET)-inducibleHEK293cell lines expressing either
mutant (Leu70) orWTACTG1 taggedwithN-terminal eGFP. Again, we
observed reduced incorporation of Leu70 ACTG1 into F-actin (Supp.
Fig. S2b), whereas cosedimentation assays of these cells also showed
a ∼50% reduction of Leu70 ACTG1 in the G-actin phase compared
with WT (Fig. 2D). In all cell types examined, endogenous ACTB and
ACTG1appeared tobeunaffected (Fig. 2CandD; Supp. Fig. S2c).West-
ern blotting and semiquantitative mass spectrometry on ACTG1–GFP
immunoprecipitates fromtheseHEK293 lines showedamarked reduc-
tion in the recovery of established actin-binding partners for Leu70
ACTG1 (Fig. 2E; Supp. Table S2).
Individual COL5061742 (family 7) had a DNM in TWF1
(NM_001242397.1; MIM# 610932; c.1045 C>T; (p.(Pro349Ser),
RNA not analyzed) that encodes Twinfillin-1. However, the identifi-
cation of a plausible DNM in this family is difficult to reconcile with
the presence of an affected third-degree maternal relative (Fig. 1),
unless the microphthalmia in this individual is coincidental. The eye
phenotype of this relative is detailed as one smaller eye and low vision,
but unfortunately more detailed clinical information or DNA were
not available. Twinfilins are highly conserved ubiquitous actin-binding
proteins that influence actin polymerization by forming 1:1 complexes
with ADP–actin monomers to moderate F-actin filament assembly
(Palmgren, Vartiainen, & Lappalainen, 2002). Twf1 also influences the
depolymerization and severing of actin filaments (Johnston, Collins,
& Goode, 2015; Moseley et al., 2006). The Twinfilin-1 p.(Pro349Ser)
substitution is located at the C-terminal “tail” region, out with the
canonical actin interaction ADF-H domains (Fig. 2A). This region was
implicated in determining binding affinity to F-actin, and complete
deletion of the C-terminal tail significantly reduces barbed-end cap-
ping activity (Paavilainen et al., 2007). In addition, the yeast Twinfilin
tail region alone can bind F-actin, and contributes to the binding of the
full-length protein, whereas loss of the tail region significantly affects
F-actin depolymerization in vitro (Johnston et al., 2015). TET-inducible
HEK293 cells expressing the WT and mutant Twinfilin-1 failed to
identify any significant protein–protein interaction differences using
immunoprecipitation with mass spectrometry (Supp. Table S2), and
cosedimentation assays showed no differences in F-/G-actin phase
distributions. However, transient transfection of FLAG-tagged, WT
ACTG1 into these HEK293 cells showed slightly increased binding of
variant Twinfilin-1 to ACTG1, compared with WT TWF1 (Supp. Fig.
S2D).
Individual COL5001071 (family 1)was found to have aDNMc.1823
A>G; (p.(Asn608Ser), RNA not analyzed) in LCP1 (NM_002298.4;
MIM#153430) that encodes LCP1 (or L-plastin/plastin-2), a conserved
F-actin filament cross-linking protein of the plastin family found in
structures involved in cell adhesion,motility, and invasion, such as focal
adhesions, membrane ruffles, and cell projections (Janji et al., 2006).
LCP1 contains two actin-binding domains, and the p.(Asn608Ser) vari-
ant is located within the fourth of four calponin homology domains,
in the second actin-binding domain (Fig. 2A). The variant was not pre-
dicted to affect LCP1protein stability by in silico analysis but structural
modelingpredicts this residue tobeon the surfaceof theprotein (Supp.
Fig. S2e). The variant was assessed using TET-inducible HEK293 cells
expressing WT and mutant versions of GFP-tagged LCP1. We did not
observe any reduction of protein stability (not shown), and both ver-
sions strongly associated with actin, but no clear differences in bind-
ing were observed by mass spectrometry. Cosedimentation analysis
revealed these cells had increased signal in the F-actin phase com-
paredwithWT (Supp. Fig. S2e). Thismay indicate abnormal LCP1–actin
interactions or increased F-actin stability in an LCP1-Ser608 contain-
ing cellular environment.
Targeted resequencing of 380 affected individuals with OC
revealed no further plausible causative variants in any of the DNM
genes identified here. All alleles, with the exception of the variants
in PPP1R15B (MIM# 613257) and STAB2 (MIM# 608561), had ExAC
allele frequencies of zero (Supp. Table S1). Using established online
tools (SIFT [http://sift.bii.a-star.edu.sg/index.html] and Polyphen-2
[http://genetics.bwh.harvard.edu/pph2/index.shtml]) to assess the
biochemical impact of the encoded amino acid substitutions, only
the ABI3BP (MIM# 606279) DNM c.2009A>G; p.(Asp670Gly) was
predicted to encode a possibly damaging substitution (Supp. Table
S1). ABI3BP has two fibronectin type II domains, but a role for this
protein in development has not been firmly established. A recent
Abi3bp knock-out mouse study revealed no overt phenotype (Yang
et al., 2016); however, the ABI3BP locus has been associatedwith optic
disk morphology in a meta-analysis GWAS study (Springelkamp et al.,
2015). None of the other genes have been implicated in developmental
eye disorders, and no ocular phenotypes have been reported in mouse
knock-out models for their orthologues.
Thiswork strongly supports a causative role for a recurrent de novo
nonsynonymous variant affectingACTG1 in human coloboma, although
its precise role in eye development requires further investigation. It
was remarkable that two other actin-interacting proteins were impli-
cated from theDNM screen; however, the clinical and biochemical evi-
dence for causation is significantly less compelling, and these variants
cannot currently be considered pathogenic. Trio-based genome-wide
sequence analysis shows promise in identifying novel genetic causes
and genetic mechanisms for OC, but a significantly larger number of
families have to be analyzed to determine the true number of disease-
associated loci for this important eyemalformation.
All datasets supporting the conclusions of this article are included
within the article and the Supp. files: Table S1, Table S2, Figure
S1, Figure S2, Figure S2 Legend, and Supp. Materials and Meth-
ods. The UK10K exome data are available via European Genome-
phenome Archive (https://www.ebi.ac.uk/ega/home) under the study
accession number EGAS00001000127. Mass spectrometry data are
available in EBI Pride repository as a ProteomeXchange submission
http://www.ebi.ac.uk/pride/; (ID# PXD005090).
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